Bausch Health Profile

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 35px;;'>BHC</div>
Analyze Filter   Earning Report: February 19, 2020
Equity ratings for Bausch Health Companies are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 28, 2019 and ending today January 26, 2020. Click here to learn more.

Bausch Health Profile

Upcoming quarterly earning report is expected on February 19, 2020. Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Bausch Health Companies Inc. was founded in 1983 and is headquartered in Laval, Canada. Bausch Health operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 21100 people. more on Bausch Health
Bausch Health Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Bausch Health Companies SEC Filings
Bausch Health SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameBausch Health Companies
Older SymbolVRX
Thematic Classification
Currently Active Investing Idea
  Pharmaceutical Products
View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Bausch Health Companies
Piotroski F Score
Academic score to determine the current strength of Bausch Health Companies financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Financial Strength
Bausch Health Companies ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Debt to Equity Ratio
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Profitability
Few selected profitability drivers of Bausch Health representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
EBITDA Margin
Gross Margin
Profit Margin
Bausch Health Companies (BHC) is traded on BATS Exchange in USA. It is located in 2150 St. Elzear Boulevard West and employs 21,100 people. Bausch Health Companies was previously known as Valeant Pharmaceuticals International and was traded on BATS Exchange under the symbol VRX. Bausch Health is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with total capitalization of 7.67 B. Bausch Health Companies runs under Healthcare sector within Drug Manufacturers?Specialty & Generic industry. The entity has 352.27 M outstanding shares of which 18.1 M shares are currently shorted by investors with about 4.62 days to cover shorted positions. The company has about 878 M in cash with 1.85 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.49.
Check Bausch Health Probability Of Bankruptcy

Bausch Health Companies Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Bausch Health Against Markets

Continue to Trending Equities. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Company logos by clearbit